Abstracts

Citation

Ceejay L. Boyce, Marley D. Bishop, Sheila M. Styrchak, Kevin Knowles, Cindy Vavro, Rohan Hazra, Ellen Townley, Robert Nixon, Robert A. Smith, Geoffrey S. Gottlieb, Theodore D. Ruel, Andrew A. Wiznia, Lisa M. Frenkel, IMPAACT P1093 Team. Prevalence and dynamics of drug resistance during dolutegravir-containing treatment in a pediatric population living with HIV-1 (IMPAACT P1093). Presented at: IAS 2023.

Citation

Dustin Huynh, Mina Nikanjam, Coleen K. Cunningham, Elizabeth J. McFarland, Petronella Muresan, Charlotte Perlowski, Dwight Yin, Jack Moye, Lucio Gama, Martin Gaudinski, Edmund V. Capparelli. INFANT AND ADULT VRC07-523LS POPULATION PHARMACOKINETIC MODELING TO PREDICT HIV PREVENTION IN BREASTFED INFANTS. Presented at: American College of Clinical Pharmacology.

Citation

CL Boyce, RA Smith, R Nixon, MD Bishop, SM Styrchak, K Knowles, S Brummel, TD Ruel, A Wiznia, S Lockman, L Chinula, PK Drain, GS Gottlieb, LM Frenkel. Genotypic and Phenotypic Dolutegravir Resistance in Pregnant Women and Children Living with HIV-1. Presented at: International Workshop on HIV Drug Resistance and Treatment Strategies; 2023 Sep 20.

Citation

Ceejay Boyce. Prevalence and dynamics of drug resistance during dolutegravir-containing treatment in a pediatric population living with HIV-1 (IMPAACT P1093). Presented at: IAS 2023; 2023 Jul 26.